192 related articles for article (PubMed ID: 1592090)
1. Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.
Soboslay PT; Weiss N; Dreweck CM; Taylor HR; Brotman B; Schulz-Key H; Greene BM
Exp Parasitol; 1992 Jun; 74(4):367-80. PubMed ID: 1592090
[TBL] [Abstract][Full Text] [Related]
2. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.
Lüder CG; Soboslay PT; Prince AM; Greene BM; Lucius R; Schulz-Key H
Parasitology; 1993 Jul; 107 ( Pt 1)():87-97. PubMed ID: 8356001
[TBL] [Abstract][Full Text] [Related]
3. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection.
Soboslay PT; Dreweck CM; Taylor HR; Brotman B; Wenk P; Greene BM
J Immunol; 1991 Jul; 147(1):346-53. PubMed ID: 2051025
[TBL] [Abstract][Full Text] [Related]
4. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
[TBL] [Abstract][Full Text] [Related]
5. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of an Onchocerca volvulus cDNA clone encoding a microfilarial surface-associated antigen.
Lustigman S; Brotman B; Johnson EH; Smith AB; Huima T; Prince AM
Mol Biochem Parasitol; 1992 Jan; 50(1):79-93. PubMed ID: 1542318
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
[TBL] [Abstract][Full Text] [Related]
8. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).
Lucius R; Kern A; Seeber F; Pogonka T; Willenbücher J; Taylor HR; Pinder M; Ghalib HW; Schulz-Key H; Soboslay P
Trop Med Parasitol; 1992 Sep; 43(3):139-45. PubMed ID: 1281926
[TBL] [Abstract][Full Text] [Related]
9. Antigenicity and specificity of very low molecular weight Onchocerca volvulus polypeptides in the range 2.2-12.5 kD.
Hoffmann WH; Blanke CH; Maier JM; Lüder CG; Schulz-Key H; Soboslay PT
Trop Med Int Health; 1997 Jul; 2(7):635-45. PubMed ID: 9270732
[TBL] [Abstract][Full Text] [Related]
10. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.
MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965
[TBL] [Abstract][Full Text] [Related]
11. Onchocerca volvulus: immunization of chimpanzees with X-irradiated third-stage (L3) larvae.
Prince AM; Brotman B; Johnson EH; Smith A; Pascual D; Lustigman S
Exp Parasitol; 1992 May; 74(3):239-50. PubMed ID: 1582477
[TBL] [Abstract][Full Text] [Related]
12. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
[TBL] [Abstract][Full Text] [Related]
13. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
[TBL] [Abstract][Full Text] [Related]
14. Onchocerca volvulus: parasitologic and serologic responses in experimentally infected chimpanzees and mangabey monkeys.
Eberhard ML; Dickerson JW; Tsang VC; Walker EM; Ottesen EA; Chandrashekar R; Weil GJ; Trpis M; Strobert E; Constantinidis I
Exp Parasitol; 1995 May; 80(3):454-62. PubMed ID: 7729480
[TBL] [Abstract][Full Text] [Related]
15. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
Tawill SA; Gallin M; Erttmann KD; Kipp W; Bamuhiiga J; Büttner DW
Trans R Soc Trop Med Hyg; 1996; 90(1):85-9. PubMed ID: 8730320
[TBL] [Abstract][Full Text] [Related]
16. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an immunodominant Onchocerca volvulus antigen with patient sera and a monoclonal antibody.
Lucius R; Schulz-Key H; Büttner DW; Kern A; Kaltmann B; Prod'hon J; Seeber F; Walter RD; Saxena KC; Diesfeld HJ
J Exp Med; 1988 Apr; 167(4):1505-10. PubMed ID: 3356969
[TBL] [Abstract][Full Text] [Related]
18. Primate model for onchocerciasis research.
Greene BM
Ciba Found Symp; 1987; 127():236-43. PubMed ID: 3595323
[TBL] [Abstract][Full Text] [Related]
19. The effect of ivermectin treatment on the antibody response to antigens of Onchocerca volvulus.
Gillespie AJ; Lustigman S; Rivas-Alcala AR; Bradley JE
Trans R Soc Trop Med Hyg; 1994; 88(4):456-60. PubMed ID: 7570844
[TBL] [Abstract][Full Text] [Related]
20. Immunity to onchocerciasis: recognition of larval antigens by humans putatively immune to Onchocerca volvulus infection.
Nutman TB; Steel C; Ward DJ; Zea-Flores G; Ottesen EA
J Infect Dis; 1991 May; 163(5):1128-33. PubMed ID: 2019761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
